Top Non-Invasive Brain Trauma Monitoring Devices Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Non-Invasive Brain Trauma Monitoring Devices Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Non-Invasive Brain Trauma Monitoring Devices industry players.

Non-Invasive Brain Trauma Monitoring Devices Market Competitive Landscape

Global Non-Invasive Brain Trauma Monitoring Devices Market is fragmented and highly competitive. To maintain a competitive edge and increase their market position in the worldwide non-invasive brain trauma monitoring devices market, leading companies are increasingly focusing on implementing tactics such as adopting new technology, product developments, mergers and acquisitions, joint venture, alliances, and partnerships.

In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.

Non-Invasive Brain Trauma Monitoring Devices Market Top Player's Company Profiles

  • Natus Medical Incorporated
  • Medtronic
  • Koninklijke Philips N.V.
  • GE Healthcare
  • Siemens Healthcare GmbH
  • BrainScope Company, Inc.
  • Compumedics Limited
  • Nihon Kohden Corporation
  • Elekta AB
  • Advanced Brain Monitoring, Inc.
  • Spiegelberg GmbH & Co. KG
  • Integra LifeSciences Holdings Corporation
  • Masimo Corporation
  • Cas Medical Systems, Inc.
  • Cadwell Industries, Inc.
  • Neural Analytics, Inc.
  • OMRON Corporation
  • BioDirection, Inc.
  • Vittamed Corporation
  • Draegerwerk AG & Co. KGaA

Non-Invasive Brain Trauma Monitoring Devices Market Recent Developments

  • In July 2022, United States Department of Defense’s Defense Advanced Research Projects Agency(DARPA) launched a research project to revolutionize brain injury diagnosis on the battlefield. The DARPA project is aimed at developing new technologies that would allow doctors to detect intracranial pressure without the need for invasive diagnostic testing and specialised surgical procedures.
  • In February 2022, the Ohio state university researchers successfully tested in the lab a tiny biosensor they developed to help detect biomarkers tied to traumatic brain injuries. The chip contains electronic components known as field-effect transistors, which emit an electrical signal after sensing the chemical of interest and can be detected and evaluated outside the body.

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Non-Invasive Brain Trauma Monitoring Devices Market size was valued at USD 10.93 Billion in 2024 and is poised to grow from USD 12.08 Billion in 2025 to USD 26.84 Billion by 2033, growing at a CAGR of 10.5% during the forecast period (2026–2033). 

Global Non-Invasive Brain Trauma Monitoring Devices Market is fragmented and highly competitive. To maintain a competitive edge and increase their market position in the worldwide non-invasive brain trauma monitoring devices market, leading companies are increasingly focusing on implementing tactics such as adopting new technology, product developments, mergers and acquisitions, joint venture, alliances, and partnerships. 'Medtronic plc (Ireland) ', 'Nihon Kohden Corporation (Japan) ', 'Integra LifeSciences Holdings Corporation (US) ', 'Raumedic AG (Germany) ', 'Advanced Brain Monitoring, Inc. (US) ', 'Cadwell Industries, Inc. (US) ', 'Masimo Corporation (US) ', 'GE Healthcare (US) ', 'Philips Healthcare (Netherlands) ', 'Siemens Healthineers AG (Germany) ', 'Compumedics Limited (Australia) ', 'NeuroWave Systems Inc. (US) ', 'Rimed Ltd. (Israel) '

The market for non-invasive brain trauma monitoring devices has been driven by factors like rising illness prevalence, technical progress, and rising awareness of neurological disorders and their treatment. The market for non-invasive brain trauma monitoring devices has also been driven by reduced prices compared to invasive treatments, the absence of any maintenance requirements, and compact device size. Neurological diseases are significantly more likely to occur as people age. For instance, around 6.0% of persons have disability linked to neurodegenerative illnesses and over 20.0% of adults over 60 have neurological problems. As a result, it is projected that the growing ageing population will positively impact the growth of the market.

Standardization of brain monitoring procedures, as well as an increase in the number of clinical trials for neuro-cognitive illnesses, are likely to provide a favourable opportunity for the market of non-invasive brain damage monitoring devices.

Globally, North America dominated the Global Non-Invasive Brain Trauma Monitoring Devices Market in 2021. This is because the healthcare sector in North America is expanding rapidly. North America is anticipated to lead the worldwide non-invasive brain trauma monitoring devices market in terms of geography due to the presence of several technology and pharmaceutical businesses in nations like Canada and the U.S. Additionally, a rise in the prevalence of traumatic brain injuries and the cost of treatment are both contributing to the market's expansion.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Non-Invasive Brain Trauma Monitoring Devices Market
Non-Invasive Brain Trauma Monitoring Devices Market

Report ID: SQSG35A2094

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE